new GP contract

New standards launched to improve public involvement in research

New national standards to improve the quality of public involvement in research.

Old sales techniques are history and sales forces must adapt

Despite all the rhetoric about multichannel marketing, patient centricity and the inexorable rise of digital, the most effective sales channel is still standing ‘two...

How to concentrate sales efforts in the right place

Right place, right time In part two of a series looking at the effective use of data, Dr Graham Leask addresses how to concentrate sales...

Sales force awakens to boost ROI

Sales force awakens Karen Bell, Director of Business Development at Ashfield Commercial and Clinical UK, on maximising return on investment.  Sales force effectiveness (SFE) is about...

The rise of digital marketing: pharma and social media

    Social media is a prerequisite for most businesses, but how has the historically reticent pharma industry been adapting? Graeme Smith Managing Partner, Fortis Pharma Consulting The highly–regulated...

Marketing Focus: the shift from treatment to prevention

Read part one of Setting the scene in the June edition of Pf Magazine here. PART TWO: Setting the scene Dr Graham Leask and Stewart Adkins...

Marketing Focus: helping modern marketeers to thrive

PART ONE: Setting the scene Introducing a new series of ‘Marketing Focus’ articles, helping modern marketeers to thrive in the changing healthcare environment. In the first...

MHRA calls for “right first time” approach to advertising

The MHRA is to take steps to protect against misleading medicines advertising messages as some breaches in regulations were exposed in a new report.

Marketing award for Schering-Plough

Schering-Plough has achieved success at this year’s UK Marketing Excellence Awards, receiving the award for best medical supplier. The company fought off competition from 3M...
CDMO Sterling Pharma Solutions has received a Queen’s Award

Takeda campaign scoops marketing award

Takeda scored a double achievement at this year’s Pharmaceutical Marketing Excellence Awards (PMEA) by winning the Marketing Campaign of the Year award and being...

Latest articles

NICE to work with GW Pharma on cannabidiol evaluation

NICE to work with GW Pharma on cannabidiol evaluation

NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...
NHS Spine marks five years of being run as an open source service

NHS Spine marks five-year anniversary

NHS Spine is marking five years since it was brought in house by NHS Digital and run as an open source service for the...
robot holding chess piece: Cyber threats in healthcare

Cyber threats in healthcare: What are the risks?

FireEye have released a new report detailing cyber threats facing the healthcare industry. The report focuses on the three types of threat most common in...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
Roche's Hemlibra® available on NHS

NHS England makes Roche’s Hemlibra® available on NHS

NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
Cannuba supports 20,000-strong pilot study on medical cannabis

UK’s first national medical cannabis pilot study launched

CBD and full spectrum cannabis oil brand, Cannuba, is supporting the UK’s first national pilot study for medical cannabis, Project TWENTY21, which launched earlier...
Positive results for long acting injectable HIV treatment regimen

Positive phase III study results for injectable HIV-treatment regimen

ViiV Healthcare has announced positive headline results from its global phase III ATLAS-2M study of the investigational, long-acting, injectable, 2-drug regimen (2DR) of ViiV...
NICE to work with GW Pharma on cannabidiol evaluation

NICE to work with GW Pharma on cannabidiol evaluation

NICE has announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription